BA3021

· BioAtla, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BA3021, covering 2025-09-26 to 2025-09-26. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 2 Open Label Study of BA3021 in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck [Phase 2]

See pricing